Alkem Laboratories Q2 Results FY27: Revenue Rises 13.77% to Rs 4,551.99 Cr, PAT Rs 667.13 Cr
- November 12, 2026
- Posted by: Harsh Piplani
- Category: Results
Quick Answer
Alkem Laboratories Q2 Results FY27 were declared on 12 November 2026 and cover the July to September 2026 quarter on a consolidated basis. Revenue rose 13.77% YoY to Rs 4,551.99 Cr from Rs 4,000.99 Cr, which is clear YoY growth in the quarterly results. Net profit was Rs 667.13 Cr against Rs 779.11 Cr a year earlier, a fall of 14.37% YoY.
Alkem Laboratories Ltd (ALKEM) Q2 Results FY27 announced on 12 November 2026, covering the company’s financial performance for the July to September quarter. On the results date, the consolidated results showed revenue of Rs 4,551.99 Cr and PAT of Rs 667.13 Cr, and Alkem Laboratories Q2 Results FY27 also record Operating Profit of Rs 1,025.19 Cr. These are the numbers that investors tracking the stock on NSE and BSE will want to see first.
This Alkem Laboratories Q2 Results review from Univest is a results analysis of the financial highlights, business drivers, outlook and risks behind the numbers. It begins with the Financial Highlights table below, which places this quarter beside the same quarter last year.
Click Here – Get Free Investment Predictions
Alkem Laboratories Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 4551.99 Cr | Rs 4000.99 Cr | +13.77% YoY |
| Operating Profit | Rs 1025.19 Cr | Rs 920.77 Cr | +11.34% YoY |
| Net Profit (PAT) | Rs 667.13 Cr | Rs 779.11 Cr | -14.37% YoY |
Source: company filing for Alkem Laboratories Q2 Results FY27, 12 November 2026. Figures in Rs Crore, Consolidated basis.
Key Takeaways from Alkem Laboratories Q2 Results: What Stands Out
- Revenue: Rs 4,551.99 Cr, up 13.77% YoY from Rs 4,000.99 Cr in the same quarter last year, which is the first figure to register.
- Net profit: Rs 667.13 Cr against Rs 779.11 Cr, a YoY fall of 14.37% captured in Alkem Laboratories Q2 Results FY27.
- Operating Profit: Rs 1,025.19 Cr versus Rs 920.77 Cr a year ago, a rise of 11.34% that shows YoY growth at the operating level.
- Net profit margin: 14.7% against 19.5% in the comparison quarter, on a Consolidated basis, as the consolidated results show for July to September.
- Return on equity: 18.29% in FY26, a reference point that the performance analysis below places beside these quarterly figures.
Alkem Laboratories Q2 Results FY27: Performance Analysis
The numbers show revenue rising 13.77% YoY to Rs 4,551.99 Cr, Operating Profit climbing to Rs 1,025.19 Cr and net profit moving to Rs 667.13 Cr. Alkem Laboratories Q2 Results FY27 therefore pair top-line growth with a lower net profit. This section sets that quarterly results picture out step by step.
Revenue added Rs 551.00 Cr over the Rs 4,000.99 Cr reported in the same quarter last year. Operating Profit grew from Rs 920.77 Cr to Rs 1,025.19 Cr, an increase of Rs 104.42 Cr, while net profit was Rs 111.98 Cr lower than the Rs 779.11 Cr a year earlier. In Alkem Laboratories Q2 Results, these three movements form the core of the results analysis.
What to track in later disclosures is whether the revenue base of Rs 4,551.99 Cr and the YoY growth in Operating Profit carry into the next filings. Net profit of Rs 667.13 Cr now sits below the year-ago figure, and the Univest app lists each update as it arrives. The reported figures show what changed, and the disclosed drivers come next in the business factors.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Revenue Growth – The business factors behind the quarterly results start with the top line, since revenue grew 13.8% year on year to Rs 4,551.99 Cr in the latest quarter, as recorded in Alkem Laboratories Q2 Results FY27.
Return on Equity – Return on equity was 18.29% in FY26, an annual measure that sits behind the consolidated results and shows the return earned on shareholder funds over the last full year.
Return on Capital Employed – Return on capital employed was 21.28% in FY26, so the full-year return on capital sits alongside the quarterly revenue growth of 13.77%. These factors set up the FY27 outlook for net profit.
FY27 Outlook After Alkem Laboratories Q2 Results
The FY27 outlook for Alkem Laboratories depends on what subsequent quarters and disclosed sector conditions show. Full-year FY27 results will build quarter by quarter, and this results analysis treats the Q2 figures as one input rather than a forecast.
Net profit of Rs 667.13 Cr and revenue of Rs 4,551.99 Cr give a reference point for later disclosures. Alkem Laboratories Q2 Results FY27 will be read alongside the next filings, and investors can follow those updates on the Univest Screener. The risks that sit beside these figures come next.
Key Risks to Watch After Alkem Laboratories Q2 Results FY27
Net Profit Decline
Net profit fell 14.4% year on year to Rs 667.13 Cr. Alkem Laboratories Q2 Results FY27 show this fall beside higher revenue, which makes the net profit line the one to watch in later filings.
Narrower Net Profit Margin
Net profit margin narrowed to 14.7% from 19.5% in the comparison quarter. Against that base, the YoY growth in Operating Profit to Rs 1,025.19 Cr deserves attention as the next quarters are reported.
Volatile Quarterly Net Profit
Quarterly net profit has been volatile, ranging from Rs 236.46 Cr to Rs 779.11 Cr over the last 5 quarters. The Rs 667.13 Cr reported now sits inside that range, which is why consecutive quarters matter for the conclusion.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
Alkem Laboratories Q2 Results FY27 show revenue of Rs 4,551.99 Cr, Operating Profit of Rs 1,025.19 Cr and net profit of Rs 667.13 Cr. These quarterly results also carry the volatility noted in the risks above, so later filings matter. In Alkem Laboratories Q2 Results, the consolidated results show revenue and Operating Profit higher YoY and net profit lower. Investors should consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on Alkem Laboratories Q2 Results FY27
What are Alkem Laboratories Q2 Results FY27?
Ans. Alkem Laboratories Q2 Results FY27 are the consolidated quarterly results for July to September 2026, showing revenue of Rs 4,551.99 Cr and net profit of Rs 667.13 Cr, as summarised in the Quick Answer.
What is the results date for Alkem Laboratories Q2 Results FY27?
Ans. The results date for Alkem Laboratories Q2 Results FY27 is 12 November 2026, so the quarterly results cover July to September 2026, while the Quick Answer and opening paragraphs repeat this date.
What revenue was reported in Alkem Laboratories Q2 Results FY27?
Ans. Alkem Laboratories Q2 Results FY27 reported revenue of Rs 4,551.99 Cr, compared with Rs 4,000.99 Cr a year earlier, which means revenue rose Rs 551.00 Cr, as the Financial Highlights table shows.
What net profit was reported in Alkem Laboratories Q2 Results FY27?
Ans. Net profit stood at Rs 667.13 Cr in Alkem Laboratories Q2 Results FY27, compared with Rs 779.11 Cr a year earlier, so the Key Takeaways section marks a YoY fall of 14.37%.
How much YoY growth did revenue show in Alkem Laboratories Q2 Results FY27?
Ans. Revenue showed YoY growth of 13.77% in Alkem Laboratories Q2 Results FY27, rising to Rs 4,551.99 Cr from Rs 4,000.99 Cr, while the Performance Analysis section explains the Rs 551.00 Cr increase.
Did net profit rise or fall in Alkem Laboratories Q2 Results?
Ans. Net profit fell in Alkem Laboratories Q2 Results, moving from Rs 779.11 Cr to Rs 667.13 Cr, which means the Key Risks section records the decline alongside a narrower net profit margin.
What was the Operating Profit in Alkem Laboratories Q2 Results FY27?
Ans. Operating Profit was Rs 1,025.19 Cr in Alkem Laboratories Q2 Results FY27, against Rs 920.77 Cr a year earlier, a rise of 11.34%, as set out in the Financial Highlights and Performance Analysis sections.
Are Alkem Laboratories Q2 Results consolidated results or standalone results?
Ans. Alkem Laboratories Q2 Results are consolidated results, so every figure covers the group, while the Conclusion repeats the consolidated basis for revenue, Operating Profit and net profit.
What business factors shaped Alkem Laboratories Q2 Results FY27?
Ans. Revenue growth of 13.8% YoY, return on equity of 18.29% and return on capital employed of 21.28% in FY26 shaped Alkem Laboratories Q2 Results FY27, as the Key Business Factors section details.
What are the key risks after Alkem Laboratories Q2 Results FY27?
Ans. The key risks after Alkem Laboratories Q2 Results FY27 are a net profit fall of 14.4%, a net profit margin of 14.7% against 19.5%, and volatile quarterly net profit, as the Key Risks section explains.
What is the outlook after Alkem Laboratories Q2 Results?
Ans. The outlook after Alkem Laboratories Q2 Results depends on subsequent quarters and disclosed sector conditions, so the Rs 667.13 Cr net profit is a reference point, as the FY27 Outlook section notes.
Where can I find the complete Alkem Laboratories Q2 Results FY27 data?
Ans. The Financial Highlights table in this article lists revenue, Operating Profit and net profit for both quarters, while the Univest Screener page carries more data on Alkem Laboratories Q2 Results FY27.
